4//SEC Filing
Ciulla Thomas 4
Accession 0001209191-23-002993
CIK 0001539029other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 4:39 PM ET
Size
5.6 KB
Accession
0001209191-23-002993
Insider Transaction Report
Form 4
Ciulla Thomas
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-01-10$1.62/sh−2,170$3,515→ 305,590 total
Footnotes (2)
- [F1]The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.6115 to $1.621 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001815426
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 4:39 PM ET
- Size
- 5.6 KB